Free Trial

Spectral Medical (TSE:EDT) Stock Passes Above 200-Day Moving Average - Here's Why

Spectral Medical logo with Medical background

Key Points

  • Spectral Medical Inc. (TSE:EDT) stock recently crossed above its 200-day moving average of C$1.02, reaching a high of C$1.65 before closing at C$1.53.
  • The company, focused on treatments for septic shock, has a market cap of C$442.38 million and a debt-to-equity ratio of 26.03.
  • Currently, Spectral Medical shares are down by 3.8% and show a PE ratio of -21.86 indicating negative earnings.
  • MarketBeat previews the top five stocks to own by November 1st.

Spectral Medical Inc. (TSE:EDT - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$1.02 and traded as high as C$1.65. Spectral Medical shares last traded at C$1.53, with a volume of 138,762 shares.

Spectral Medical Trading Down 3.8%

The company has a fifty day simple moving average of C$1.42 and a two-hundred day simple moving average of C$1.02. The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03. The company has a market cap of C$442.38 million, a PE ratio of -21.86 and a beta of 0.13.

About Spectral Medical

(Get Free Report)

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Spectral Medical Right Now?

Before you consider Spectral Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.

While Spectral Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.